(Q60629727)
Statements
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas (English)
M P Ducreux
S Leboulleux
D Malka
P Kergoat
D Elias
T de Baere
J C Sabourin
P Duvillard
P Lasser
M Schlumberger